Market Overview

Perrigo Buys Remaining Stake in Cobrek Pharma for ~$45M

Related PRGO
#PreMarket Primer: Monday, April 7: World Bank Lowers China's 2014 Growth Forecast
Mylan to Buy Swedish Company? - Analyst Blog
Horizon Inks $660M Reverse Merger With Ireland's Vidara (Fox Business)

Perrigo Company (Nasdaq: PRGO) today announced that it has signed a definitive merger agreement and has completed the acquisition of Cobrek Pharmaceuticals, Inc. (Cobrek), a privately-held, Chicago, Illinois-based drug development company, for approximately $45 million on a cash free and debt free basis.

Posted-In: News M&A

 

Most Popular

Related Articles (PRGO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free